Glimepiride Tablet
Product Images NDC 51655-120

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 51655-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Glimepiride Structure)

Structure (Glimepiride Structure)
Chemical structure of Glimepiride depicted as a 2D molecular diagram showing its atoms and bonds, including rings and functional groups.*
FDA Label Image

Label (51655 120 26 Rev A 12 22 Nhc)

Label (51655 120 26   Rev A 12 22 Nhc)
Label for Glimepiride Tablets, USP 4 mg, oral tablets. The label indicates a package size of 90 tablets, prescription-only status, storage instructions at 25°C with allowed excursions, and warnings to keep out of reach of children. The product is labeled by Northwind Health Company, LLC with NDC 51655-120.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.